Related Experiment Video

Updated: Jun 14, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Endogenous LKB1 knockdown accelerates G(1)/S transition through p53 and p16 pathways

Xiaoyan Liang1, Pilong Wang, Qing Gao

  • 1Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Cancer Biology & Therapy
|April 7, 2010
PubMed

Insights

Loss of the tumor suppressor LKB1 (Liver kinase B1) accelerates cell cycle progression in normal cells. This occurs via the p53 and p16 pathways, suggesting a mechanism for cancer development.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • The tumor suppressor LKB1 (Liver kinase B1) is frequently inactivated in various cancers, including Peutz-Jeghers syndrome and non-small cell lung carcinoma.
  • Understanding how LKB1 inactivation initiates oncogenesis in normal cells is crucial but remains unclear.

Purpose of the Study:

  • To investigate the role of endogenous LKB1 in regulating cell cycle progression in normal human cells.
  • To elucidate the molecular mechanisms by which LKB1 loss contributes to malignant transformation.

Main Methods:

  • Ablation of endogenous LKB1 expression in human embryonic kidney 293T (HEK-293T) cells and human umbilical vein endothelial cells (HUVECs) using LKB1-specific short hairpin RNAs.
  • Analysis of cell cycle progression, including G1/S transition and Rb phosphorylation.
  • Assessment of key cell cycle regulatory proteins, such as p53, p16, cyclin D1, and cyclin E.

Main Results:

  • Downregulation of LKB1 facilitated G1/S cell cycle transition.
  • Increased Rb phosphorylation (Ser807/811) was observed in LKB1-ablated cells.
  • Reduced expression of p53 and p16 was detected, while cyclin D1 and cyclin E levels remained unchanged.

Conclusions:

  • Endogenous LKB1 knockdown accelerates cell cycle progression through the G1/S checkpoint in normal HEK-293T and HUVEC cells.
  • The observed acceleration is, at least in part, mediated by the decline of p53 and p16 signaling pathways.
  • These findings provide a potential mechanism for how LKB1 loss in normal cells contributes to malignancy.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...